Preterm Fetal Growth Restriction and Developmental Care
早产胎儿生长受限和发育护理
基本信息
- 批准号:6915736
- 负责人:
- 金额:$ 47.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-07-01 至 2007-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Fetal growth restriction (FGR) increases the already substantial risk of prematurity for infants' survival, overall function and later learning competence. Of the 12% of prematurely born infants in the US each year, more than 5% failed to grow appropriately in the womb due to placental insufficiency. These infants present immediate significant challenges to Newborn Intensive Care Units (NICU); more than 70% will go on to develop learning disabilities and require special educational services. It is postulated that the NICU's stressful environment may exacerbate the FGR infant's low threshold of reactivity and jeopardize already compromised brain development. The proposed project will test the effectiveness of an in-NICU intervention for such infants. It will consist of efforts to individualize all care to the infant's thresholds of sensitivity and to thereby improve neural fiber tract development (MRI) and neurophysiologic functioning (EEG). This in turn is expected to result in better behavioral adaptations. Thirty FGR preterm infants will be randomized to either a Developmental Care (E) or Standard Care (C) group. All infants will be studied within 7 days of birth (baseline) and again at 2 weeks corrected age (2w CA) (outcome). The FGR-E group is expected to show better development at 2w CA in the 3 domains to be tested, neurobehavior, electrophysiology, and brain structure. Furthermore, the FGR infants will be compared to a sample of appropriate in growth for gestational age (AGA) preterm infants for whom comparable data are available at both age points from a previous study. The FGR and AGA C and E groups will be compared in order to identify sample specific aspects of the intervention effects. This might lead to better understanding of the intervention's interaction with sample specific risk factors. The relationship and predictive success will be examined among background variables, intervention, and outcomes in the respective domains. Repeated measures multivariate analysis of variance by domain will be employed to assess sample, group and time effects as well as their interactions. Discriminate function analysis, canonical correlation, multiple regression as well as path analysis will be employed in order to model domain and across age relationships, and to predict intervention effectiveness. Results are expected to show brain-based effects of the intervention for the FGR infants, mediated by stress reduction. This is expected to bring them closer in functioning and brain structural development to their AGA peers. The study will be significant in understanding ways to reduce long-term functional morbidities in FGR infants, as well as in identifying opportunities for enhancing last trimester brain development.
描述(由申请人提供):胎儿生长受限(FGR)增加了早产对婴儿生存、整体功能和后期学习能力的重大风险。在美国每年12%的早产儿中,超过5%的婴儿由于胎盘功能不全而无法在子宫内正常生长。这些婴儿对新生儿重症监护室(NICU)提出了直接的重大挑战;超过70%的婴儿将发展为学习障碍,需要特殊的教育服务。据推测,新生儿重症监护室的压力环境可能会加剧FGR婴儿的低阈值的反应和危害已经受损的大脑发育。拟议的项目将测试新生儿重症监护室干预对这些婴儿的有效性。它将包括努力使所有护理个体化,以适应婴儿的敏感阈值,从而改善神经纤维束发育(MRI)和神经生理功能(EEG)。这反过来又会导致更好的行为适应。将30名FGR早产儿随机分配至发育护理(E)组或标准护理(C)组。所有婴儿将在出生后7天内(基线)进行研究,并在2周龄(2周CA)时再次进行研究(结局)。预计FGR-E组在2周CA时在待测试的3个领域(神经行为、电生理学和脑结构)中显示出更好的发育。此外,将FGR婴儿与适合胎龄生长(阿加)的早产婴儿样本进行比较,这些早产婴儿在先前研究的两个年龄点都有可比数据。将比较FGR和阿加C和E组,以确定干预效果的样本特定方面。这可能会导致更好地理解干预措施与样本特定风险因素的相互作用。将在各自领域的背景变量、干预和结果之间检查关系和预测成功。将采用按领域的重复测量多变量方差分析来评估样本、组和时间效应及其相互作用。将采用判别函数分析、典型相关、多元回归和路径分析,以建立领域和跨年龄关系的模型,并预测干预效果。预期结果将显示干预对FGR婴儿的基于大脑的影响,通过减轻压力来介导。这有望使他们在功能和大脑结构发育方面与阿加同龄人更接近。这项研究对于了解如何减少FGR婴儿的长期功能性发病率以及确定增强最后三个月大脑发育的机会具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HEIDELISE ALS其他文献
HEIDELISE ALS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HEIDELISE ALS', 18)}}的其他基金
Preterm Fetal Growth Restriction and Developmental Care
早产胎儿生长受限和发育护理
- 批准号:
7933162 - 财政年份:2009
- 资助金额:
$ 47.87万 - 项目类别:
Does Early Experience Improve Preterm Neurodevelopment?
早期经验能否改善早产神经发育?
- 批准号:
7847566 - 财政年份:2006
- 资助金额:
$ 47.87万 - 项目类别:
Does Early Experience Improve Preterm Neurodevelopment?
早期经验能否改善早产神经发育?
- 批准号:
7048138 - 财政年份:2006
- 资助金额:
$ 47.87万 - 项目类别:
Does Early Experience Improve Preterm Neurodevelopment?
早期经验能否改善早产神经发育?
- 批准号:
7434365 - 财政年份:2006
- 资助金额:
$ 47.87万 - 项目类别:
Does Early Experience Improve Preterm Neurodevelopment?
早期经验能否改善早产神经发育?
- 批准号:
7264515 - 财政年份:2006
- 资助金额:
$ 47.87万 - 项目类别:
Does Early Experience Improve Preterm Neurodevelopment?
早期经验能否改善早产神经发育?
- 批准号:
7622688 - 财政年份:2006
- 资助金额:
$ 47.87万 - 项目类别:
PRETERM FETAL GROWTH RESTRICTION AND DEVELOPMENT CARE
早产胎儿生长受限和发育护理
- 批准号:
7379253 - 财政年份:2006
- 资助金额:
$ 47.87万 - 项目类别:
PRETERM FETAL GROWTH RESTRICTION AND DEVELOPMENT CARE
早产胎儿生长受限和发育护理
- 批准号:
7204533 - 财政年份:2005
- 资助金额:
$ 47.87万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 47.87万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 47.87万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 47.87万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 47.87万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 47.87万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 47.87万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 47.87万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 47.87万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 47.87万 - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
$ 47.87万 - 项目类别: